CN1252065A - 取代的噻唑烷二酮的制备方法 - Google Patents

取代的噻唑烷二酮的制备方法 Download PDF

Info

Publication number
CN1252065A
CN1252065A CN98804121A CN98804121A CN1252065A CN 1252065 A CN1252065 A CN 1252065A CN 98804121 A CN98804121 A CN 98804121A CN 98804121 A CN98804121 A CN 98804121A CN 1252065 A CN1252065 A CN 1252065A
Authority
CN
China
Prior art keywords
compound
formula
borohydride
solvate
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN98804121A
Other languages
English (en)
Chinese (zh)
Inventor
R·G·吉勒斯
N·J·刘易斯
S·莫雷
C·R·普尔
J·K·奎克
M·厄克特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27268725&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN1252065(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9703310.4A external-priority patent/GB9703310D0/en
Priority claimed from GBGB9703334.4A external-priority patent/GB9703334D0/en
Priority claimed from GBGB9703338.5A external-priority patent/GB9703338D0/en
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of CN1252065A publication Critical patent/CN1252065A/zh
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
CN98804121A 1997-02-18 1998-02-13 取代的噻唑烷二酮的制备方法 Pending CN1252065A (zh)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB9703338.5 1997-02-18
GBGB9703310.4A GB9703310D0 (en) 1997-02-18 1997-02-18 Novel process
GBGB9703334.4A GB9703334D0 (en) 1997-02-18 1997-02-18 Novel compounds
GB9703334.4 1997-02-18
GB9703310.4 1997-02-18
GBGB9703338.5A GB9703338D0 (en) 1997-02-18 1997-02-18 Novel process

Publications (1)

Publication Number Publication Date
CN1252065A true CN1252065A (zh) 2000-05-03

Family

ID=27268725

Family Applications (1)

Application Number Title Priority Date Filing Date
CN98804121A Pending CN1252065A (zh) 1997-02-18 1998-02-13 取代的噻唑烷二酮的制备方法

Country Status (29)

Country Link
EP (2) EP0970063A1 (https=)
JP (2) JP2001514619A (https=)
KR (1) KR20000071138A (https=)
CN (1) CN1252065A (https=)
AP (1) AP1359A (https=)
AR (1) AR011447A1 (https=)
AU (1) AU6622398A (https=)
BG (1) BG64311B1 (https=)
BR (1) BR9807395A (https=)
CA (1) CA2281695C (https=)
CZ (1) CZ296272B6 (https=)
DZ (1) DZ2430A1 (https=)
EA (1) EA199900754A1 (https=)
HU (1) HUP0001459A3 (https=)
ID (1) ID22222A (https=)
IL (1) IL131392A (https=)
IN (1) IN188379B (https=)
MA (1) MA24475A1 (https=)
MY (1) MY129475A (https=)
NO (2) NO313290B1 (https=)
NZ (1) NZ337179A (https=)
OA (1) OA11148A (https=)
PE (1) PE71899A1 (https=)
PL (1) PL195482B1 (https=)
SK (2) SK287512B6 (https=)
TR (1) TR199902019T2 (https=)
TW (1) TWI222446B (https=)
UY (1) UY24886A1 (https=)
WO (1) WO1998037073A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7091359B2 (en) 1997-11-04 2006-08-15 Smithkline Beecham Plc Process for the preparation of thiazolidinedione derivatives
GB9723295D0 (en) 1997-11-04 1998-01-07 Smithkline Beecham Plc Novel process
US7045519B2 (en) 1998-06-19 2006-05-16 Chiron Corporation Inhibitors of glycogen synthase kinase 3
UA67844C2 (uk) * 1999-04-23 2004-07-15 Смітклайн Бічам Плс Поліморф 5-[4-[2-(n-метил-n-(2-піридил)аміно)етокси]бензил]тіазолідин-2,4-діону солі малеїнової кислоти
FR2820741A1 (fr) * 2001-02-14 2002-08-16 Ppg Sipsy Procede de preparation de composes derives de thiazolidinedione, d'oxazolidinedione ou d'hydantoine
FR2820742B1 (fr) * 2001-02-14 2005-03-11 Ppg Sipsy Procede de preparation de composes derives de thiazolidinedione, d'oxazolidinedione ou d'hydantoine
MXPA05005406A (es) 2002-11-22 2005-08-03 Smithkline Beecham Corp Compuestos quimicos novedosos.
AR047541A1 (es) * 2004-02-13 2006-01-25 Sandoz Ag Fosfato de 5-[[4-[2-metil-2-piridinil-amino-etoxi]fenil]metil]-2,4 tiazolidinadiona (rosiglitazona) y sus formas polimorficas
CA2566352A1 (en) * 2004-05-12 2005-11-17 Medichem S.A. Process for the preparation of rosiglitazone
CZ297266B6 (cs) * 2004-09-10 2006-10-11 Zentiva, A. S. Zpusob prípravy rosiglitazonu
CZ297347B6 (cs) * 2004-09-21 2006-11-15 Zentiva, A. S. Zpusob prípravy rosiglitazonu
CZ298424B6 (cs) * 2005-05-24 2007-09-26 Zentiva, A. S. Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1003445B (zh) * 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物,其制备方法和用途
SG59988A1 (en) * 1987-09-04 1999-02-22 Beecham Group Plc Substituted thiazolidinedione derivatives
JPH0377875A (ja) * 1989-08-18 1991-04-03 Kaken Pharmaceut Co Ltd チアゾリジン‐2,4‐ジオン誘導体およびその製造法
ATE205206T1 (de) * 1990-04-27 2001-09-15 Sankyo Co Benzylidenthiazolidinderivate, ihre herstellung und ihre anwendung als lipidperoxid-inhibitoren
US5585495A (en) * 1991-12-20 1996-12-17 The Upjohn Company Reduction method for substituted 5-methylene-thiazolidinediones
JPH08157473A (ja) * 1994-10-06 1996-06-18 Nissan Chem Ind Ltd ピラゾール系チアゾリジン類
JPH08217717A (ja) * 1995-02-10 1996-08-27 Sumitomo Chem Co Ltd 環状ケトン系化合物、その製造法およびそれを有効成分とするゴキブリ誘引剤
EP0842933B1 (en) * 1995-05-31 2004-08-04 Sumitomo Pharmaceuticals Company, Limited Novel naphthyridine derivatives

Also Published As

Publication number Publication date
NO993949L (no) 1999-09-07
HUP0001459A3 (en) 2002-11-28
NO20023937L (no) 1999-09-07
NO313290B1 (no) 2002-09-09
AU6622398A (en) 1998-09-09
KR20000071138A (ko) 2000-11-25
OA11148A (en) 2003-04-16
CA2281695A1 (en) 1998-08-27
UY24886A1 (es) 2001-08-27
PL195482B1 (pl) 2007-09-28
CA2281695C (en) 2006-12-12
BG103735A (en) 2000-06-30
IL131392A (en) 2005-07-25
AP1359A (en) 2004-12-02
CZ292499A3 (cs) 2000-02-16
NO20023937D0 (no) 2002-08-19
NO993949D0 (no) 1999-08-17
IL131392A0 (en) 2001-01-28
TR199902019T2 (xx) 1999-12-21
CZ296272B6 (cs) 2006-02-15
MA24475A1 (fr) 1998-10-01
AR011447A1 (es) 2000-08-16
WO1998037073A1 (en) 1998-08-27
JP2009149616A (ja) 2009-07-09
MY129475A (en) 2007-04-30
PE71899A1 (es) 1999-09-15
DZ2430A1 (fr) 2003-01-11
SK287512B6 (sk) 2010-12-07
EP1770092A1 (en) 2007-04-04
EP0970063A1 (en) 2000-01-12
EA199900754A1 (ru) 2000-04-24
HUP0001459A2 (hu) 2000-10-28
TWI222446B (en) 2004-10-21
IN188379B (https=) 2002-09-14
ID22222A (id) 1999-09-16
BG64311B1 (bg) 2004-09-30
PL335163A1 (en) 2000-04-10
SK112099A3 (en) 2000-05-16
AP9901626A0 (en) 1999-09-30
NZ337179A (en) 2001-07-27
SK285979B6 (sk) 2007-12-06
JP2001514619A (ja) 2001-09-11
BR9807395A (pt) 2000-03-14

Similar Documents

Publication Publication Date Title
CN1252065A (zh) 取代的噻唑烷二酮的制备方法
CN1067077C (zh) 新的红霉素衍生物及其制备方法和药物用途
EP2598501B1 (en) N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mesylate monohydrate
CN104892537B (zh) 依折麦布中间体以及依折麦布的合成方法
CN1028428C (zh) 23-(c1-c6烷基肟)-ll-f28249化合物的制备方法
CN112321589B (zh) 一种抗病毒药物瑞德西韦及其中间体的合成方法
CN110483483A (zh) 一种手性多齿氮配体化合物及其制备方法和应用
WO2001042271A1 (en) Process for production of methylcobalamin
CN101407513A (zh) 一种核苷类似物的合成方法
CN106117186A (zh) 一种伏立康唑及其中间体的制备方法
EP2330107A2 (en) Improved production method for adefovir dipivoxil
CN107857702A (zh) 一种比拉斯汀中间体的制备方法
US6632947B2 (en) Process for the preparation of substituted thiazolidinedione
US20100167408A1 (en) Palladium(0)-Dibenzylidene Acetone Complexes
CN110655507B (zh) 一种抗肿瘤类药物替加氟的制备方法
CN101074209A (zh) (z)-3-(溴代亚甲基)异二氢吲哚-1-酮及其合成方法
CN111909148A (zh) 一种吲哚嗪衍生物及其制备方法
CN117229266B (zh) 一种合成雷莫司琼外消旋体及其盐的方法
CN103562209A (zh) 一种制备普拉格雷的方法及普拉格雷盐酸盐新晶型
JP4870296B2 (ja) ヒノキチオール配糖体の製造方法
CN1660842A (zh) 用于制备环戊烷甲酰胺类化合物的中间体及其制备方法
WO2010118273A1 (en) Ruthenium catalysts for the production of hydrocodone, hydromorphone or a derivative thereof
AU774839B2 (en) Process for the preparation of substituted thiazolidinedione
CN101654432B (zh) 2-吡啶酮的一种n-烷基化方法
CN116396247A (zh) 一种紫衫烷类药物中间体的制备方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication